Application Nr Approved Date Route Status External Links
ANDA091608 2014-06-02 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Mefenamic Acid And Other Treatment Options Before Deciding To Use Mefenamic Acid. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (see Warnings). Mefenamic Acid Is Indicated: For Relief Of Mild To Moderate Pain In Patients ≥14 Years Of Age, When Therapy Will Not Exceed One Week (7 Days). For Treatment Of Primary Dysmenorrhea.

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. D&c Yellow No. 10 D&C YELLOW NO. 10 Molecular DYE-Dye
2. Fd&c Yellow No. 6 FD&C YELLOW NO. 6 Molecular DYE-Dye
3. Gelatin GELATIN Unresolved
4. Propylene Glycol PROPYLENE GLYCOL Molecular MISC-Miscellaneous FS-Substances permitted as optional ingredient in a standardized food.
5. Shellac SHELLAC Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mefenamic Acid MEFENAMIC ACID ZINC20241